Nichtenzymatische Glykierung und oxidativer Streß bei chronischen Erkrankungen und Diabetes mellitus
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Medizinische Klinik
- Vol. 94 (1) , 29-38
- https://doi.org/10.1007/bf03044692
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Advanced glycation end products in diabetic complicationsCurrent Opinion in Endocrinology, Diabetes and Obesity, 1996
- Histones from Diabetic Rats Contain Increased Levels of Advanced Glycation End ProductsBiochemical and Biophysical Research Communications, 1995
- Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Aminoguanidine Has Both Pro-oxidant and Antioxidant Activity Toward LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetesBiochemical and Biophysical Research Communications, 1990
- Production and characterization of antibodies to advanced glycation products on proteinsBiochemical and Biophysical Research Communications, 1989
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylationLife Sciences, 1988